(c) 2024 PillSync.com

24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD) [see CLINICAL STUDIES ( 14 )]. Desvenlafaxine extended-release tablet, is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).

Lupin Pharmaceuticals, Inc.


8 months ago ROUND PINK LU S61 24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet

ROUND PINK LU S61

8 months ago ROUND PINK LU S61 24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet

LU S61 ROUND PINK

16 HOW SUPPLIED/STORAGE AND HANDLING Desvenlafaxine extended-release tablets are available as follows: 25 mg, tan, biconvex, round shaped film-coated tablets, debossed with "LU" on one side and "S67" on the other side. NDC 68180-604-06, bottle of 30 tablets in unit-of-use package 50 mg, light pink, biconvex, round shaped film-coated tablets, debossed with "LU" on one side and "S61" on the other side. NDC 68180-592-06, bottle of 30 tablets in unit-of-use package 100 mg, reddish-orange, biconvex, round shaped film-coated tablets, debossed with "LU" on one side and "S62" on the other side. NDC 68180-593-06, bottle of 30 tablets in unit-of-use package Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Each tablet contains 38 mg, 76 mg or 152 mg of

DESVENLAFAXINE SUCCINATE monohydrate equivalent to 25 mg, 50 mg or 100 mg of desvenlafaxine, respectively.


More pills like ROUND LU S61












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site